Wells Fargo & Company »

Immunovant shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 80k 25.42
2025-09-30 $724k 45k 16.12
2025-06-30 $580k 36k 16.00
2025-03-31 $492k 29k 17.09
2024-12-31 $695k 28k 24.77
2024-09-30 $534k 19k 28.51
2024-06-30 $515k 20k 26.40
2024-03-31 $571k 18k 32.31
2023-12-31 $694k 17k 42.13
2023-09-30 $2.6M 67k 38.39
2023-06-30 $1.3M 67k 18.97
2022-09-30 $1.0k 123 8.13
2022-06-30 $2.0k 520 3.85
2021-12-31 $106k 12k 8.49
2021-09-30 $0 53 0.00
2021-06-30 $574k 30k 18.87
2021-03-31 $1.0M 63k 16.02
2020-12-31 $1.9M 40k 46.20
2020-09-30 $2.3M 64k 35.20
2020-06-30 $1.1M 43k 24.37